Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|26|3797-3806

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.26, 2015-01, pp. : 3797-3806

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting 7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 538-554

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 121-129

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Development of Radioligands for Imaging α7 Nicotinic Acetylcholine Receptors in the Brain

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 15, 2010-10 ,pp. : 1544-1557

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Neuroprotective, Neurotrophic or Both?

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 613-622

Bentham Science Publishers

Access to resources Recommend Favorite